Q1 2026 Holdings
Filed 2026-05-14 | 73 holdings | $979.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series TrustPut | PUT | 78464A950 | $105.4M | 825,000 | 10.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $57.9M | 2,876,407 | 5.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $54.9M | 654,746 | 5.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $50.6M | 1,314,189 | 5.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $40.9M | 357,903 | 4.2% |
| Immunome Inc(IMNM) | COM | 45257U108 | $40.5M | 1,850,278 | 4.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $37.8M | 991,930 | 3.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $36.4M | 354,914 | 3.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $33.7M | 302,530 | 3.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $32.9M | 2,002,040 | 3.4% |
| Erasca Inc(ERAS) | COM | 29479A108 | $30.0M | 1,851,812 | 3.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $28.5M | 124,658 | 2.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $27.0M | 1,503,045 | 2.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $26.6M | 306,000 | 2.7% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $23.1M | 71,552 | 2.4% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $22.2M | 1,135,935 | 2.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $20.8M | 888,987 | 2.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $18.5M | 466,345 | 1.9% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $16.7M | 339,613 | 1.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $16.3M | 460,314 | 1.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $13.9M | 1,100,010 | 1.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $12.5M | 196,028 | 1.3% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $12.3M | 1,208,986 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.5M | 197,759 | 1.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $11.3M | 166,349 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $10.3M | 414,236 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $9.4M | 186,618 | 1.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $9.3M | 50,967 | 1.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $9.1M | 98,514 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.4M | 144,981 | 0.9% |
| Uniqure NVCall | CALL | N90064901 | $8.2M | 500,000 | 0.8% |
| Savara Inc(SVRA) | COM | 805111101 | $7.8M | 1,430,982 | 0.8% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $7.6M | 717,725 | 0.8% |
| Syndax Pharmaceuticals IncCall | CALL | 87164F905 | $7.5M | 320,000 | 0.8% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $7.4M | 150,908 | 0.8% |
| Compugen LTD(CGEN) | ORD | M25722105 | $7.1M | 3,315,845 | 0.7% |
| Celcuity IncCall | CALL | 15102K900 | $6.2M | 54,500 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $6.1M | 511,127 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.9M | 35,850 | 0.6% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $5.8M | 179,700 | 0.6% |
| Cerus Corp(CERS) | COM | 157085101 | $5.8M | 3,176,547 | 0.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $5.7M | 178,378 | 0.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $5.0M | 1,911,785 | 0.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.7M | 71,203 | 0.5% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $4.7M | 684,908 | 0.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $4.5M | 859,049 | 0.5% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $4.2M | 144,255 | 0.4% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $3.9M | 301,729 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $3.3M | 560,651 | 0.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.2M | 419,949 | 0.3% |